Home Stats & Services Victim Assistance Seeking Victim Information Identifying Victims in the Investigation of New England Compounding Center...

Identifying Victims in the Investigation of New England Compounding Center

Identifying Victims in the Investigation of
the New England Compounding Center

Between approximately May and September, 2012, the New England Compounding Center (NECC) distributed three lots of preservative-free methylprednisolone acetate (MPA) to approximately 76 out-patient surgery centers in 20 different states. The Centers for Disease Control and Prevention (CDC), in collaboration with state and local health departments and the Food and Drug Administration (FDA), continues to investigate and monitor a multistate outbreak of fungal meningitis and other infections among patients who received contaminated preservative-free MPA steroid injections from these three lots.

Both the CDC and FDA have dedicated websites that provide updated information about the outbreak and about NECC:

http://www.cdc.gov/HAI/outbreaks/meningitis.html

http://www.fda.gov/Drugs/DrugSafety/FungalMeningitis/default.htm

The FBI, the FDA’s Office of Criminal Investigations, and other federal agencies opened a criminal investigation of NECC in October 2012. The FBI is concerned about the devastating impact the outbreak has had on victims and their families. Providing information and assistance to victims is an important part of our work. If you or a family member were a victim of the fungal meningitis outbreak, we request you submit the information identified below.

The FBI is legally mandated to identify victims of federal crimes under investigation and provide these victims with information, assistance services, and resources. The FBI’s Office of Victim Assistance (OVA) provides assistance to crime victims nationwide. 

Please submit the following information to the FBI if you or a family member:

(1) received an injection of preservative-free methylprednisolone acetate (MPA);

(2) in dosage of 80 mg/ml;

(3) at one of the listed facilities;

(4) between May 1, 2012 and October 1, 2012.

What we will need to know:

  • Your basic contact information (name, address, country, telephone numbers, e-mail address);
  • Some brief information about your medical history
  • Any additional information that may be helpful.

How to provide the above information:

  1. Preferred Method—Via an online form on the FBI.gov website: https://forms.fbi.gov/necc
  2. If you do not have access to a computer, you may mail your information to:


FBI Boston, One Center Plaza, Suite 600, Boston, MA 02108, Attention: Health Care Fraud Squad (C-4)

If you believe that another medication distributed by NECC caused harm to you or a family member, please complete the information as specified in the online form.  

The FBI will need your contact information so we can keep you informed of potential progress of the federal investigation as deemed appropriate, as well as provide you updated information regarding your rights in this matter. 

If we determine that you are a victim, we will be in touch with you. Please note: due to the number of expected responses, you may not hear back from us for several weeks. If it is determined you are not a potential victim, you will be removed from the FBI’s victim notification system.

If you have investigative information that might help our case, please use our electronic public leads and tips form at https://tips.fbi.gov/.

In addition to the information provided by the CDC and FDA, the following are resources that may be of help to you: